Breakpoints

124 Folgen

1. #124 – Dosing Consult: Cefepime

   Vom: 10.10.2025
2. #122 – The Role of The Pharmacist in Antimicrobial Stewardship in Latin America

   Vom: 26.9.2025
3. #123 – Rol del Farmacéutico en los PROA en América Latina

   Vom: 26.9.2025
4. #121 – Finding BALANCE in Antibiotic Durations: The BALANCE Trial

   Vom: 19.9.2025
5. #120 – What’s Pneu in Community-Acquired Pneumonia

   Vom: 22.8.2025
6. #119 – Dosing Consult: Fluconazole

   Vom: 25.7.2025
7. #118 – Hot Topics: What You May Have Missed in Infectious Diseases 2024-2025 (LIVE from MAD-ID)

   Vom: 27.6.2025
8. #117 – Amnio-Oh-No You Didn’t: Modernizing Antimicrobial Regimens for Intraamniotic Infections

   Vom: 23.5.2025
9. #116 – SNAP Out of It: Rethinking Antistaphylococcal Penicillins for S. Aureus Bacteremia – The SNAP Trial PSSA/MSSA Results

   Vom: 4.5.2025
10. #115 – Silver Lining of Shortages: Blood Culture Best Practices

    Vom: 25.4.2025
11. #114 – Dosing Consult: Amoxicillin/Clavulanate

    Vom: 11.4.2025
12. #113 – Ask ChatGPT: The Role of AI in Healthcare

    Vom: 28.3.2025
13. #112 – Say It Ain't Steno: Stenotrophomonas maltophilia Review

    Vom: 28.2.2025
14. #111 – Dosing Consult: Rifampin Part 2

    Vom: 14.2.2025
15. #110 – A Bone to Pick: Biofilm Busters for Prosthetic Joint Infections

    Vom: 24.1.2025
16. #109 – IDWeek 2024 Recap: Practice Changing Papers and ID Potpourri

    Vom: 27.12.2024
17. #108 – IDWeek 2024 Recap: Late Breaker Abstracts and Stewardship Talks

    Vom: 20.12.2024
18. #107 – Dosing Consult: Valganciclovir

    Vom: 29.11.2024
19. #106 – Stewie Struggles: EHR Edition

    Vom: 8.11.2024
20. #105 – Bringing Positive Vibes Only: Breaking News & Emerging Hypotheses for Gram-Positive Bacterial Infections

    Vom: 25.10.2024